Suppr超能文献

肾结石和膀胱结石患者的终末期肾病和死亡率风险。

Risk of ESRD and Mortality in Kidney and Bladder Stone Formers.

机构信息

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.

Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.

出版信息

Am J Kidney Dis. 2018 Dec;72(6):790-797. doi: 10.1053/j.ajkd.2018.06.012. Epub 2018 Aug 23.

Abstract

RATIONALE & OBJECTIVES: Kidney stones have been associated with increased risk for end-stage renal disease (ESRD). However, it is unclear whether there is also an increased risk for mortality and if these risks are uniform across clinically distinct categories of stone formers.

STUDY DESIGN

Historical matched-cohort study.

SETTING & PARTICIPANTS: Stone formers in Olmsted County, MN, between 1984 and 2012 identified using International Classification of Diseases, Ninth Revision codes. Age- and sex-matched individuals who had no codes for stones were the comparison group.

PREDICTOR

Stone formers were placed into 5 mutually exclusive categories after review of medical charts: incident symptomatic kidney, recurrent symptomatic kidney, asymptomatic kidney, bladder only, and miscoded (no stone).

OUTCOMES

ESRD, mortality, cardiovascular mortality, and cancer mortality.

ANALYTICAL APPROACH

Cox proportional hazards models with adjustment for baseline comorbid conditions.

RESULTS

Overall, 65 of 6,984 (0.93%) stone formers and 102 of 28,044 (0.36%) non-stone formers developed ESRD over a mean follow-up of 12.0 years. After adjusting for baseline hypertension, diabetes mellitus, dyslipidemia, gout, obesity, and chronic kidney disease, risk for ESRD was higher in recurrent symptomatic kidney (HR, 2.34; 95% CI, 1.08-5.07), asymptomatic kidney (HR, 3.94; 95% CI, 1.65-9.43), and miscoded (HR, 6.18; 95% CI, 2.25-16.93) stone formers, but not in incident symptomatic kidney or bladder stone formers. The adjusted risk for all-cause mortality was higher in asymptomatic kidney (HR, 1.40; 95% CI, 1.18-1.67) and bladder (HR, 1.37; 95% CI, 1.12-1.69) stone formers. Chart review of asymptomatic and miscoded stone formers suggested increased risk for adverse outcomes related to diagnoses including urinary tract infection, cancer, and musculoskeletal or gastrointestinal pain.

CONCLUSIONS

The higher risk for ESRD in recurrent symptomatic compared with incident symptomatic kidney stone formers suggests that stone events are associated with kidney injury. The clinical indication for imaging in asymptomatic stone formers, the correct diagnosis in miscoded stone formers, and the cause of a bladder outlet obstruction in bladder stone formers may explain the higher risk for ESRD or death in these groups.

摘要

背景与目的

肾结石与终末期肾病(ESRD)风险增加相关。然而,尚不清楚是否存在死亡率风险增加的情况,以及这些风险在临床上不同的结石形成者分类中是否一致。

研究设计

历史匹配队列研究。

研究地点和参与者

在明尼苏达州奥姆斯特德县,1984 年至 2012 年间通过国际疾病分类,第九版代码确定肾结石患者。无结石代码的年龄和性别匹配的个体为对照组。

预测因素

在回顾病历后,将结石患者分为 5 个互斥类别:偶发性症状性肾结石、复发性症状性肾结石、无症状性肾结石、单纯膀胱结石和错误编码(无结石)。

结局

ESRD、死亡率、心血管死亡率和癌症死亡率。

分析方法

采用 Cox 比例风险模型,根据基线合并症进行调整。

结果

总体而言,65 例肾结石患者(0.93%)和 102 例非肾结石患者(0.36%)在平均 12.0 年的随访中发展为 ESRD。在调整了基线高血压、糖尿病、血脂异常、痛风、肥胖和慢性肾脏病后,复发性症状性肾结石(HR,2.34;95%CI,1.08-5.07)、无症状性肾结石(HR,3.94;95%CI,1.65-9.43)和错误编码(HR,6.18;95%CI,2.25-16.93)的肾结石患者发生 ESRD 的风险更高,但偶发性症状性肾结石或膀胱肾结石患者的风险没有增加。无症状肾结石(HR,1.40;95%CI,1.18-1.67)和膀胱结石(HR,1.37;95%CI,1.12-1.69)患者的全因死亡率调整风险更高。对无症状和错误编码肾结石患者的病历回顾表明,与尿路感染、癌症和肌肉骨骼或胃肠道疼痛等诊断相关的不良结局风险增加。

结论

与偶发性症状性肾结石相比,复发性症状性肾结石患者发生 ESRD 的风险更高,这表明结石事件与肾脏损伤有关。在无症状结石患者中进行影像学检查的临床指征、错误编码结石患者的正确诊断以及膀胱结石患者的膀胱出口梗阻的原因可能解释了这些患者发生 ESRD 或死亡的风险更高。

相似文献

1
Risk of ESRD and Mortality in Kidney and Bladder Stone Formers.
Am J Kidney Dis. 2018 Dec;72(6):790-797. doi: 10.1053/j.ajkd.2018.06.012. Epub 2018 Aug 23.
2
Urolithiasis and the risk of ESRD.
Clin J Am Soc Nephrol. 2012 Sep;7(9):1409-15. doi: 10.2215/CJN.03210312. Epub 2012 Jun 28.
3
Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers.
Clin J Am Soc Nephrol. 2017 Mar 7;12(3):476-482. doi: 10.2215/CJN.06600616. Epub 2017 Feb 1.
4
Kidney stones and the risk for chronic kidney disease.
Clin J Am Soc Nephrol. 2009 Apr;4(4):804-11. doi: 10.2215/CJN.05811108. Epub 2009 Apr 1.
5
Evaluation of inactive Matrix-Gla-Protein (MGP) as a biomarker for incident and recurrent kidney stones.
J Nephrol. 2020 Feb;33(1):101-107. doi: 10.1007/s40620-019-00623-0. Epub 2019 Jun 20.
6
Vascular calcification and bone mineral density in recurrent kidney stone formers.
Clin J Am Soc Nephrol. 2015 Feb 6;10(2):278-85. doi: 10.2215/CJN.06030614. Epub 2015 Jan 29.
8
Predictors of Symptomatic Kidney Stone Recurrence After the First and Subsequent Episodes.
Mayo Clin Proc. 2019 Feb;94(2):202-210. doi: 10.1016/j.mayocp.2018.09.016. Epub 2018 Dec 4.
9
Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota.
Am J Kidney Dis. 2010 Jan;55(1):61-8. doi: 10.1053/j.ajkd.2009.08.008. Epub 2009 Oct 22.
10
Dietary Risk Factors for Incident and Recurrent Symptomatic Kidney Stones.
Mayo Clin Proc. 2022 Aug;97(8):1437-1448. doi: 10.1016/j.mayocp.2022.04.016. Epub 2022 Aug 1.

引用本文的文献

1
Impact of preoperative double-J stent placement on stone recurrence following flexible ureteroscopic lithotripsy.
J Int Med Res. 2025 Jul;53(7):3000605251359610. doi: 10.1177/03000605251359610. Epub 2025 Jul 25.
3
Decoding coffee's chlorogenic acid: genetic-network pharmacology insights on kidney stones.
Urolithiasis. 2025 Jun 21;53(1):124. doi: 10.1007/s00240-025-01776-3.
7
Kidney stone characteristics in diabetics versus nondiabetics at a tertiary care center in Saudi Arabia.
Urol Ann. 2025 Jan-Mar;17(1):26-31. doi: 10.4103/ua.ua_55_24. Epub 2025 Jan 18.
10
Impact of diet on renal stone formation.
J Family Med Prim Care. 2024 Nov;13(11):4800-4809. doi: 10.4103/jfmpc.jfmpc_770_24. Epub 2024 Nov 18.

本文引用的文献

1
The Changing Incidence and Presentation of Urinary Stones Over 3 Decades.
Mayo Clin Proc. 2018 Mar;93(3):291-299. doi: 10.1016/j.mayocp.2017.11.018. Epub 2018 Feb 14.
2
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States.
Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2016.12.004.
3
Risk of Hypertension among First-Time Symptomatic Kidney Stone Formers.
Clin J Am Soc Nephrol. 2017 Mar 7;12(3):476-482. doi: 10.2215/CJN.06600616. Epub 2017 Feb 1.
4
The association of nephrolithiasis with metabolic syndrome and its components: a cross-sectional analysis.
Ther Clin Risk Manag. 2017 Jan 6;13:41-48. doi: 10.2147/TCRM.S125480. eCollection 2017.
5
Nephrolithiasis as a risk factor of chronic kidney disease: a meta-analysis of cohort studies with 4,770,691 participants.
Urolithiasis. 2017 Oct;45(5):441-448. doi: 10.1007/s00240-016-0938-x. Epub 2016 Nov 11.
6
Kidney Function After the First Kidney Stone Event.
Mayo Clin Proc. 2016 Dec;91(12):1744-1752. doi: 10.1016/j.mayocp.2016.08.014. Epub 2016 Oct 21.
7
Urinary calculi and risk of cancer: a nationwide population-based study.
Medicine (Baltimore). 2014 Dec;93(29):e342. doi: 10.1097/MD.0000000000000342.
8
The risk of kidney cancer in patients with kidney stones: a systematic review and meta-analysis.
QJM. 2015 Mar;108(3):205-12. doi: 10.1093/qjmed/hcu195. Epub 2014 Sep 9.
9
Risk of chronic and end stage kidney disease in patients with nephrolithiasis.
J Urol. 2014 Nov;192(5):1440-5. doi: 10.1016/j.juro.2014.05.117. Epub 2014 Jun 11.
10
Kidney stones and cardiovascular events: a cohort study.
Clin J Am Soc Nephrol. 2014 Mar;9(3):506-12. doi: 10.2215/CJN.04960513. Epub 2013 Dec 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验